Allarity Therapeutics, Inc. (ALLR) — Institutional Holders, Q2 2026
20 institutional investment managers reported a ALLR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ALLR in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- RENAISSANCE TECHNOLOGIESAdded · +103,425 sh+$133.4K
- Militia Capital ManagementNew · +98,978 sh+$127.7K
- CITADEL ADVISORSNew · +91,748 sh+$118.4K
- HRT FINANCIALNew · +37,003 sh+$47.7K
- JANE STREET GROUPNew · +36,021 sh+$46.5K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -35,526 sh-$45.8K
- TWO SIGMA SECURITIESSold out · -12,334 sh-$15.9K
- NORTHERNTrimmed · -11,569 sh-$14.9K
- XTX Topco LtdTrimmed · -8,083 sh-$10.4K
- CITIGROUPSold out · -7,766 sh-$10.0K
ALLR 13F holders ranked 1–20 of 20
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES#1 · 331,509 sh | 331,509 | $427.6K | <0.01% | +45.3% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 171,795 sh | 171,795 | $221.6K | 0.00% | 0.0% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 154,867 sh | 154,867 | $199.8K | 0.00% | -18.7% |
| 4 | STATE STREET#4 · 137,600 sh | 137,600 | $177.5K | 0.00% | 0.0% |
| 5 | Militia Capital Management#5 · 98,978 sh | 98,978 | $127.7K | <0.01% | New |
| 6 | CITADEL ADVISORS#6 · 91,748 sh | 91,748 | $118.4K | 0.00% | New |
| 7 | VANGUARD FIDUCIARY#7 · 74,913 sh | 74,913 | $96.6K | 0.00% | 0.0% |
| 8 | NORTHERN#8 · 36,534 sh | 36,534 | $47.1K | 0.00% | -24.1% |
| 9 | HRT FINANCIAL#9 · 37,003 sh | 37,003 | $47.0K | <0.01% | New |
| 10 | JANE STREET GROUP#10 · 36,021 sh | 36,021 | $46.5K | 0.00% | New |
| 11 | TWO SIGMA INVESTMENTS#11 · 27,492 sh | 27,492 | $35.5K | 0.00% | 0.0% |
| 12 | UBS Group AG#12 · 26,589 sh | 26,589 | $34.3K | 0.00% | +14.8% |
| 13 | XTX Topco Ltd#13 · 20,884 sh | 20,884 | $26.9K | <0.01% | -27.9% |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#14 · 17,221 sh | 17,221 | $22.2K | 0.00% | New |
| 15 | Virtu Financial#15 · 15,322 sh | 15,322 | $20.0K | <0.01% | New |
| 16 | Tower Research Capital (TRC)#16 · 2,650 sh | 2,650 | $3.4K | <0.01% | New |
| 17 | Caitong International Asset Management , Ltd#17 · 22 sh | 22 | $28.00 | 0.00% | +2100.0% |
| 18 | FMR#18 · 13 sh | 13 | $17.00 | 0.00% | New |
| 19 | DANSKE BANK A/S#19 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 20 | JONES FINANCIAL COMPANIES LLLP#20 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
Funds that sold out of ALLR in Q2 2026 (2)
Held ALLR at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| TWO SIGMA SECURITIES12,334 sh | 12,334 | $13.4K |
| CITIGROUP7,766 sh | 7,766 | $8.5K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.